Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

Research found that semaglutide, the active substance in Ozempic and the weight-loss drug Wegovy, could help curb alcohol ...

Madison Burgess turned to Ozempic for weight loss in 2023. She saw quick results but developed severe side effects when her dose increased. Switching to microdosing, she ultimately lost 60 lbs.

For the first time a semaglutide weight loss drug has been approved for use in Australia to also treat cardiovascular disease ...

RANI READ THE FULL RANI RESEARCH REPORT On February 5 th , Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shared its preclinical readout from the RT-116 study demonstrating successful oral delivery of ...

Considering GLP-1 agonists tend to perform better at higher doses, it remains to be seen if Mounjaro 15 mg would outperform ... their weight-loss product as Wegovy. It’s still Ozempic, but ...

Jake Van Naarden, executive vice president and president, Lilly Oncology, will take part in a fireside chat at 1:50 p.m., Eastern ... (donanemab-azbt, 350 mg/20 mL every four weeks injection ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

But the results add to evidence from animal studies and reports that people are finding drugs like Ozempic and Wegovy helpful to ... The drugs, known as GLP-1 receptor agonists, work by mimicking ...